265 related articles for article (PubMed ID: 16649995)
1. The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.
Masuda K; Sakamoto K; Kojima M; Aburatani T; Ueda T; Ueda H
FEBS J; 2006 May; 273(10):2184-94. PubMed ID: 16649995
[TBL] [Abstract][Full Text] [Related]
2. Requirement for both H and L chain V regions, VH and VK joining amino acids, and the unique H chain D region for the high affinity binding of an anti-phosphotyrosine antibody.
Ruff-Jamison S; Glenney JR
J Immunol; 1993 Apr; 150(8 Pt 1):3389-96. PubMed ID: 7682239
[TBL] [Abstract][Full Text] [Related]
3. Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous V(H) genes.
de Kruif J; Kramer A; Visser T; Clements C; Nijhuis R; Cox F; van der Zande V; Smit R; Pinto D; Throsby M; Logtenberg T
J Mol Biol; 2009 Apr; 387(3):548-58. PubMed ID: 19361421
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding.
Pellequer JL; Chen Sw; Roberts VA; Tainer JA; Getzoff ED
J Mol Recognit; 1999; 12(4):267-75. PubMed ID: 10440998
[TBL] [Abstract][Full Text] [Related]
5. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
6. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
7. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
[TBL] [Abstract][Full Text] [Related]
8. Antibody affinity maturation in vitro using unconjugated peptide antigen.
Iwai H; Oztürk B; Ihara M; Ueda H
Protein Eng Des Sel; 2010 Apr; 23(4):185-93. PubMed ID: 20123883
[TBL] [Abstract][Full Text] [Related]
9. Human framework adaptation of a mouse anti-human IL-13 antibody.
Fransson J; Teplyakov A; Raghunathan G; Chi E; Cordier W; Dinh T; Feng Y; Giles-Komar J; Gilliland G; Lollo B; Malia TJ; Nishioka W; Obmolova G; Zhao S; Zhao Y; Swanson RV; Almagro JC
J Mol Biol; 2010 Apr; 398(2):214-31. PubMed ID: 20226193
[TBL] [Abstract][Full Text] [Related]
10. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD
J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938
[TBL] [Abstract][Full Text] [Related]
11. Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens.
Lloyd C; Lowe D; Edwards B; Welsh F; Dilks T; Hardman C; Vaughan T
Protein Eng Des Sel; 2009 Mar; 22(3):159-68. PubMed ID: 18974080
[TBL] [Abstract][Full Text] [Related]
12. Relative noncovalent association constant between immunoglobulin H and L chains is unrelated to their expression or antigen-binding activity.
Hamel PA; Klein MH; Smith-Gill SJ; Dorrington KJ
J Immunol; 1987 Nov; 139(9):3012-20. PubMed ID: 3117886
[TBL] [Abstract][Full Text] [Related]
13. Dissection of the IgNAR V domain: molecular scanning and orthologue database mining define novel IgNAR hallmarks and affinity maturation mechanisms.
Fennell BJ; Darmanin-Sheehan A; Hufton SE; Calabro V; Wu L; Müller MR; Cao W; Gill D; Cunningham O; Finlay WJ
J Mol Biol; 2010 Jul; 400(2):155-70. PubMed ID: 20450918
[TBL] [Abstract][Full Text] [Related]
14. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
15. The invariant tryptophan in an H chain V region is not essential to antibody binding.
Sharon J
J Immunol; 1988 Apr; 140(8):2666-9. PubMed ID: 3128602
[TBL] [Abstract][Full Text] [Related]
16. Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndrome.
Lambrianides A; Giles I; Ioannou Y; Mason L; Latchman DS; Manson JJ; Isenberg DA; Rahman A
Arthritis Rheum; 2007 Jul; 56(7):2392-401. PubMed ID: 17599767
[TBL] [Abstract][Full Text] [Related]
17. Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside.
Rojas G; Talavera A; Munoz Y; Rengifo E; Krengel U; Angström J; Gavilondo J; Moreno E
J Immunol Methods; 2004 Oct; 293(1-2):71-83. PubMed ID: 15541278
[TBL] [Abstract][Full Text] [Related]
18. Conserved amino acid networks involved in antibody variable domain interactions.
Wang N; Smith WF; Miller BR; Aivazian D; Lugovskoy AA; Reff ME; Glaser SM; Croner LJ; Demarest SJ
Proteins; 2009 Jul; 76(1):99-114. PubMed ID: 19089973
[TBL] [Abstract][Full Text] [Related]
19. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
[TBL] [Abstract][Full Text] [Related]
20. Affinity maturation of a V(H)H by mutational hotspot randomization.
Yau KY; Dubuc G; Li S; Hirama T; Mackenzie CR; Jermutus L; Hall JC; Tanha J
J Immunol Methods; 2005 Feb; 297(1-2):213-24. PubMed ID: 15777944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]